Jiang Chunhua, Moorthy Balaji T, Patel Devang M, Kumar Akhilesh, Morgan William M, Alfonso Belkis, Huang Jingyu, Lampidis Theodore J, Isom Daniel G, Barrientos Antoni, Fontanesi Flavia, Zhang Fangliang
Department of Molecular & Cellular Pharmacology, University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States.
Department of Human Genetics, University of Miami Leonard M. Miller School of Medicine, Miami, FL, United States.
Front Cell Dev Biol. 2020 Dec 21;8:603688. doi: 10.3389/fcell.2020.603688. eCollection 2020.
Arginyltransferase 1 (ATE1) is an evolutionary-conserved eukaryotic protein that localizes to the cytosol and nucleus. It is the only known enzyme in metazoans and fungi that catalyzes posttranslational arginylation. Lack of arginylation has been linked to an array of human disorders, including cancer, by altering the response to stress and the regulation of metabolism and apoptosis. Although mitochondria play relevant roles in these processes in health and disease, a causal relationship between ATE1 activity and mitochondrial biology has yet to be established. Here, we report a phylogenetic analysis that traces the roots of ATE1 to alpha-proteobacteria, the mitochondrion microbial ancestor. We then demonstrate that a small fraction of ATE1 localizes within mitochondria. Furthermore, the absence of ATE1 influences the levels, organization, and function of respiratory chain complexes in mouse cells. Specifically, -KO mouse embryonic fibroblasts have increased levels of respiratory supercomplexes I+III+IV. However, they have decreased mitochondrial respiration owing to severely lowered complex II levels, which leads to accumulation of succinate and downstream metabolic effects. Taken together, our findings establish a novel pathway for mitochondrial function regulation that might explain ATE1-dependent effects in various disease conditions, including cancer and aging, in which metabolic shifts are part of the pathogenic or deleterious underlying mechanism.
精氨酰转移酶1(ATE1)是一种进化保守的真核蛋白,定位于细胞质和细胞核。它是后生动物和真菌中唯一已知的催化翻译后精氨酰化的酶。精氨酰化的缺乏通过改变对压力的反应以及代谢和细胞凋亡的调节,与一系列人类疾病(包括癌症)相关联。尽管线粒体在健康和疾病的这些过程中发挥着相关作用,但ATE1活性与线粒体生物学之间的因果关系尚未确立。在这里,我们报告了一项系统发育分析,该分析将ATE1的起源追溯到线粒体的微生物祖先α-变形菌。然后我们证明一小部分ATE1定位于线粒体内。此外,ATE1的缺失会影响小鼠细胞中呼吸链复合物的水平、组织和功能。具体而言,敲除ATE1的小鼠胚胎成纤维细胞中呼吸超级复合物I+III+IV的水平增加。然而,由于复合物II水平严重降低,它们的线粒体呼吸减少,这导致琥珀酸积累和下游代谢效应。综上所述,我们的研究结果建立了一种线粒体功能调节的新途径,这可能解释了ATE1在各种疾病状态(包括癌症和衰老)中的依赖性效应,其中代谢转变是致病或有害潜在机制的一部分。